KemPharm, Inc (KMPH)

Etorro trading 970x250
KemPharm, Inc (KMPH) Logo

About KemPharm, Inc

KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. Its prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, stimulant use disorder, and CNS rare diseases, including idiopathic hypersomnia. KemPharm’s lead clinical development candidate for the treatment of stimulant use disorder, KP879, is based on its prodrug of d-methylphenidate, known as serdexmethylphnidate. In addition, the company has received FDA approval for AZSTARYS, a new once-daily treatment for attention deficit hyperactivity disorder in patents age six years and older, and for APADAZ, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen. KemPharm, Inc. has collaboration and license agreement, with KVK-Tech, Inc. The company was incorporated in 2006 and is headquartered in Celebration, Florida. Address: 1180 Celebration Boulevard, Celebration, FL, United States, 34747

KemPharm, Inc News and around…

Latest news about KemPharm, Inc (KMPH) common stock and company :

Noteworthy Wednesday Option Activity: STNG, BOX, KMPH
01 Dec, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Scorpio Tankers Inc (STNG), where a total of 10,063 contracts have traded so far, representing approximately 1.0 million underlying shares. That amounts to about 126.7% of STNG's average daily trading volume over the past month of 794,145 shares..

Noteworthy Tuesday Option Activity: SPCE, KMPH, MUSA
23 Nov, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Virgin Galactic Holdings Inc (SPCE), where a total volume of 57,807 contracts has been traded thus far today, a contract volume which is representative of approximately 5.8 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 49.5% of SPCE's average daily trading volume over the past month, of 11.7 million shares..

Implied Volatility Surging for KemPharm (KMPH) Stock Options
19 Nov, 2021 Yahoo! Finance

Investors need to pay close attention to KemPharm (KMPH) stock based on the movements in the options market lately.

How The Pieces Add Up: OMFS Targets $52
18 Nov, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Russell 2000—Dynamic Multifactor ETF (OMFS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $51.52 per unit.

Noteworthy Monday Option Activity: KMPH, CVX, STAR
15 Nov, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in KemPharm Inc (KMPH), where a total volume of 2,600 contracts has been traded thus far today, a contract volume which is representative of approximately 260,000 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 63.2% of KMPH's average daily trading volume over the past month, of 411,110 shares..

KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
10 Nov, 2021 Yahoo! Finance

Lead Independent Director Richard W. Pascoe Named Executive Chairman Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today, November 10, 2021, 4:30 p.m. ET Corporate and Regulatory Highlights Appointment of Richard W. Pascoe as Executive Chairman; Mr. Pascoe to focus on executing the Company’s strategic growth plansUplisted to The Nasdaq Global Select MarketResearch involving AZSTARYS® and serdexmethylphenidate featured in poster presentations at multiple medical con

KemPharm Announces AZSTARYS® Clinical Data to be Featured in Poster Presentation at the 2021 Virtual International Conference on ADHD
05 Nov, 2021 Yahoo! Finance

Data demonstrate efficacy of AZSTARYS in children, including 30-minute onset of action and 13-hour duration of effect Corium Continues Commercialization Effort in U.S. CELEBRATION, Fla., Nov. 05, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that research involving AZSTARYS® will be featured in a poster presentation during the 2021 Virtual International Conference on ADH

KemPharm to Report Third Quarter 2021 Results
03 Nov, 2021 Yahoo! Finance

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, November 10, 2021, 4:30 p.m. ET CELEBRATION, Fla., Nov. 03, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that the Company will host a conference call and live audio webcast on Wednesday, November 10, 2021, at 4:30 p.m. ET, to discuss its corporate and financial results for the third

Notable Friday Option Activity: TEAM, AAPL, KMPH
29 Oct, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Atlassian Corp PLC (TEAM), where a total volume of 32,854 contracts has been traded thus far today, a contract volume which is representative of approximately 3.3 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 374% of TEAM's average daily trading volume over the past month, of 878,515 shares..

AZSTARYS®, An Innovative ADHD Treatment Developed by KemPharm, to be Featured in a Poster Presentation at the 2021 Psych Congress
27 Oct, 2021 Yahoo! Finance

Pharmacokinetic data from two clinical studies of AZSTARYS demonstrated its rapid onset of action and long duration of effect CELEBRATION, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that research involving AZSTARYS® is being featured in a poster presentation during the 2021 Psych Congress being held both virtually and in-person in San Antonio, Texas, fr

Noteworthy Wednesday Option Activity: SKT, STEM, KMPH
20 Oct, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Tanger Factory Outlet Centers, Inc. (SKT), where a total volume of 3,545 contracts has been traded thus far today, a contract volume which is representative of approximately 354,500 underlying shares (given that every 1 contract represents 100 underlying shares)..

KemPharm Announces Research Involving AZSTARYS® and Serdexmethylphenidate to be Featured in Poster Presentations at Multiple Medical Conferences during ADHD Awareness Month (October)
20 Oct, 2021 Yahoo! Finance

CELEBRATION, Fla., Oct. 20, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that research involving AZSTARYS® and serdexmethylphenidate (SDX), the company’s proprietary prodrug of d-methylphenidate (d-MPH), will be featured in poster presentations during multiple medical conferences being held in October (ADHD Awareness Month). Presentations will be given at the following

KemPharm, Inc. Announces Uplisting to The Nasdaq Global Select Market
19 Oct, 2021 Yahoo! Finance

Trading to commence effective with the open of business on October 19, 2021 CELEBRATION, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that its shares of common stock have been approved for listing to The Nasdaq Global Select Market. Trading on the exchange will commence effective with the open of business on October 19, 2021, under KemPharm’s current tick

Noteworthy Tuesday Option Activity: TPX, KMPH, FIVE
12 Oct, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Tempur Sealy International, Inc. (TPX), where a total volume of 11,659 contracts has been traded thus far today, a contract volume which is representative of approximately 1.2 million underlying shares (given that every 1 contract represents 100 underlying shares)..

KemPharm to Present at the Benzinga Healthcare Small Cap Conference
27 Sep, 2021 FinancialContent
Noteworthy Friday Option Activity: M, KMPH, BIIB
24 Sep, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Macy's Inc (M), where a total of 75,713 contracts have traded so far, representing approximately 7.6 million underlying shares. That amounts to about 51.7% of M's average daily trading volume over the past month of 14.6 million shares..

KemPharm to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
23 Sep, 2021 FinancialContent
Analysts Expect VTWV Will Reach $166
22 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Russell 2000 Value ETF (VTWV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $166.34 per unit.

KemPharm to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
09 Sep, 2021 FinancialContent
KMPH Makes Notable Cross Below Critical Moving Average
08 Sep, 2021 FinancialContent

In trading on Wednesday, shares of KemPharm Inc (KMPH) crossed below their 200 day moving average of $8.90, changing hands as low as $8.83 per share. KemPharm Inc shares are currently trading off about 1.1% on the day..

Relative Strength Alert For KemPharm
23 Aug, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Noteworthy Friday Option Activity: ELF, KMPH, TWLO
20 Aug, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in e. .

KemPharm Appoints Tamara A. Seymour to Board of Directors
18 Aug, 2021 FinancialContent
Analysts See 18% Upside For The Holdings of OMFS
17 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Russell 2000—Dynamic Multifactor ETF (OMFS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $47.30 per unit.

78 Biggest Movers From Friday
16 Aug, 2021 FinancialContent

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported ...

53 Stocks Moving In Friday's Mid-Day Session
13 Aug, 2021 FinancialContent

Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The ...

KemPharm Reports Second Quarter 2021 Financial Results
12 Aug, 2021 FinancialContent
Notable Thursday Option Activity: KMPH, MEG, SDGR
12 Aug, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in KemPharm Inc (KMPH), where a total of 2,823 contracts have traded so far, representing approximately 282,300 underlying shares. That amounts to about 60.7% of KMPH's average daily trading volume over the past month of 465,095 shares..

How to Pick the Best Small Cap Biotech Stocks to Buy
10 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investing in biotech stocks isn’t for the faint of heart, but these can be some of the most lucrative equities on the market. The post How to Pick the Best Small Cap Biotech Stocks to Buy appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
10 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

KemPharm, Inc (KMPH) is a NASDAQ Common Stock listed in , ,

970x250